Because BNP and NT-proBNP serum levels are inclined to increase in SSc patients with early PAH and correlate with estimated pulmonary arterial pressure they are considered valuable biomarkers for PAH [159,160]. This evidence concerns the gene NPPB and pulmonary arterial hypertension.